专利信息

注册 | 忘记密码？

专利信息

Translation Company

查询条件展开筛选条件

[专利权人] 包含 ' VILLHAUER EDWIN BERNARD [US]'

首页 1 尾页共 2 条记录, 当前第1/1页。

	公开号	公开日	申请号	申请日

	1. US2013184311A1	2013/7/18	US201113876063	2011/10/5
	专利标题：CRYSTALLINE FORMS OF THE SODIUM SALT OF (4--CYCLOHEXYL)-ACETIC ACID 专利权人：SUTTON PAUL ALLEN [US];GIRGIS MICHAEL J [US];LIANG JESSICA [US];PRASHAD MAHAVIR [US];VILLHAUER EDWIN BERNARD [US];NOVARTIS AG [CH]; The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates to processes for making such novel crystalline forms.

	2. WO2012047948A1	2012/4/12	WO2011US54841	2011/10/5
	专利标题：NEW CRYSTALLINE FORMS OF THE SODIUM SALT OF (4- {4- [5- ( 6 - TRIFLUOROMETHYL - PYRIDIN- 3 - YLAMINO ) - PYRIDIN- 2 -YL] -PHENYL} - CYCLOHEXYL) -ACETIC ACID 专利权人：NOVARTIS AG [CH];SUTTON PAUL ALLEN [US];GIRGIS MICHAEL J [US];LIANG JESSICA [US];PRASHAD MAHAVIR [US];VILLHAUER EDWIN BERNARD [US]; The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates processes for making such novel crystalline forms.

首页 1 尾页共 2 条记录, 当前第1/1页。

当前查询条件: [专利权人] 包含 ' VILLHAUER EDWIN BERNARD [US]'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B